The latest NAV of ITI Pharma and Healthcare Fund is ₹18.28 as of 2026-08-11.
The returns of ITI Pharma and Healthcare Fund are 13.57% for 1 year, 66.27% for 3 years and NA% for 5 years, as per the latest available data. Investors should compare these returns with the category average and benchmark before making a decision.
The investment objective of ITI Pharma and Healthcare Fund : The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
ITI Pharma and Healthcare Fund has a Very High risk rating as per the fund’s riskometer. Investors should check whether this risk level matches their investment horizon, financial goals and ability to handle market volatility.
The AUM, or Assets Under Management, of ITI Pharma and Healthcare Fund is ₹262.84 crore. AUM indicates the total money managed under the scheme. Higher AUM may reflect investor confidence, but fund performance, consistency and portfolio quality should also be reviewed.
The expense ratio of ITI Pharma and Healthcare Fund is 2.69. This is the annual fee charged by the fund house for managing the scheme. A lower expense ratio can help improve net returns over the long term, but it should not be the only factor used to judge a fund.